WO2009019668A3 - Nécessaire de conditionnement pour statines et compositions à base de celles-ci - Google Patents

Nécessaire de conditionnement pour statines et compositions à base de celles-ci Download PDF

Info

Publication number
WO2009019668A3
WO2009019668A3 PCT/IB2008/053200 IB2008053200W WO2009019668A3 WO 2009019668 A3 WO2009019668 A3 WO 2009019668A3 IB 2008053200 W IB2008053200 W IB 2008053200W WO 2009019668 A3 WO2009019668 A3 WO 2009019668A3
Authority
WO
WIPO (PCT)
Prior art keywords
packaging kit
statins
compositions
absorber
oxygen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2008/053200
Other languages
English (en)
Other versions
WO2009019668A2 (fr
Inventor
Rahul Bhargava
Romi Singh
Rajeev Shanker Mathur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Priority to EP08807276A priority Critical patent/EP2178486A2/fr
Publication of WO2009019668A2 publication Critical patent/WO2009019668A2/fr
Publication of WO2009019668A3 publication Critical patent/WO2009019668A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
    • B65D81/24—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants
    • B65D81/26—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants with provision for draining away, or absorbing, or removing by ventilation, fluids, e.g. exuded by contents; Applications of corrosion inhibitors or desiccators
    • B65D81/266—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants with provision for draining away, or absorbing, or removing by ventilation, fluids, e.g. exuded by contents; Applications of corrosion inhibitors or desiccators for absorbing gases, e.g. oxygen absorbers or desiccants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10—Bag-type containers

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Food Science & Technology (AREA)
  • Mechanical Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention concerne un nécessaire de conditionnement comportant un récipient imperméable à l'oxygène scellé comprenant une statine et au moins un stabilisant choisi dans le groupe constitué d'un absorbeur d'oxygène, d'un absorbeur d'humidité ou d'une combinaison de ceux-ci. Elle concerne, en outre, un nécessaire de conditionnement pour une composition pharmaceutique solide à base de statine comprenant la composition et au moins un stabilisant choisi dans le groupe constitué d'un absorbeur d'oxygène, d'un absorbeur d'humidité ou d'une combinaison de ceux-ci dans un récipient imperméable à l'oxygène.
PCT/IB2008/053200 2007-08-09 2008-08-09 Nécessaire de conditionnement pour statines et compositions à base de celles-ci Ceased WO2009019668A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP08807276A EP2178486A2 (fr) 2007-08-09 2008-08-09 Nécessaire de conditionnement pour statines et compositions à base de celles-ci

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1698DE2007 2007-08-09
IN1698/DEL/2007 2007-08-09

Publications (2)

Publication Number Publication Date
WO2009019668A2 WO2009019668A2 (fr) 2009-02-12
WO2009019668A3 true WO2009019668A3 (fr) 2009-04-02

Family

ID=40185008

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2008/053200 Ceased WO2009019668A2 (fr) 2007-08-09 2008-08-09 Nécessaire de conditionnement pour statines et compositions à base de celles-ci

Country Status (2)

Country Link
EP (1) EP2178486A2 (fr)
WO (1) WO2009019668A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7867511B2 (en) 2004-01-23 2011-01-11 Travanti Pharma Inc. Abuse potential reduction in abusable substance dosage form
ES2842453T3 (es) * 2011-09-05 2021-07-14 Siegfried Ltd Kit que comprende un material de envasado y un producto farmacéutico o nutracéutico sólido contenido en el material de envasado
KR20140068058A (ko) 2011-09-30 2014-06-05 테이코쿠 팔마 유에스에이, 인코포레이티드 경피 패치 처리 시스템
MX357423B (es) * 2011-09-30 2018-07-09 Verde Environmental Tech Inc Sistema de desecho de medicamento general.
US11389844B2 (en) 2018-03-20 2022-07-19 Verde Environmental Technologies, Inc. Blister pack disposal system

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0513364A1 (fr) * 1990-11-07 1992-11-19 Otsuka Pharmaceutical Factory, Inc. Recipient a plusieurs chambres
EP0633013A1 (fr) * 1993-01-22 1995-01-11 Otsuka Pharmaceutical Factory, Inc. Recipient de stockage d'un medicament en poudre contenant du bicarbonate, et procede de stabilisation dudit medicament
EP0737468A2 (fr) * 1995-04-11 1996-10-16 Nissho Corporation Poche souple à deux chambres
WO2006008651A1 (fr) * 2004-07-16 2006-01-26 Pfizer Products Inc. Emballage pharmaceutique permettant de maintenir simultanement un faible taux d'humidite et un faible taux d'oxygene

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0513364A1 (fr) * 1990-11-07 1992-11-19 Otsuka Pharmaceutical Factory, Inc. Recipient a plusieurs chambres
EP0633013A1 (fr) * 1993-01-22 1995-01-11 Otsuka Pharmaceutical Factory, Inc. Recipient de stockage d'un medicament en poudre contenant du bicarbonate, et procede de stabilisation dudit medicament
EP0737468A2 (fr) * 1995-04-11 1996-10-16 Nissho Corporation Poche souple à deux chambres
WO2006008651A1 (fr) * 2004-07-16 2006-01-26 Pfizer Products Inc. Emballage pharmaceutique permettant de maintenir simultanement un faible taux d'humidite et un faible taux d'oxygene

Also Published As

Publication number Publication date
EP2178486A2 (fr) 2010-04-28
WO2009019668A2 (fr) 2009-02-12

Similar Documents

Publication Publication Date Title
EP2039366A4 (fr) Composition contenant un peptide comme principe actif
UA100228C2 (uk) Фармацевтична композиція, яка містить тетрагідрофолієву кислоту
WO2007139871A3 (fr) Méthodes et matières pour l'élaboration de simvastatine et de ses composés
IL191141A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
IL186665A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
IL195488A (en) Compounds, pharmaceuticals containing them and their uses
EP2285357B8 (fr) Compositions pharmaceutiques comprenant du brivaracetam
TWI367109B (en) Compositions comprising kakadu plum extract or acai berry extract
PL2063868T3 (pl) Kompozycje farmaceutyczne zawierające rosuwastatynę wapniową
WO2010012904A3 (fr) Nouveaux dérivés de l'oxime de cholest-4-èn-3-one, compositions pharmaceutiques les renfermant, et procédé de préparation
EP2036936A4 (fr) Résine absorbant l'oxygène, compositions de résine absorbant l'oxygène et récipients absorbant l'oxygène
WO2009147075A3 (fr) Compositions pharmaceutiques contenant une forme cristalline de posaconazole
WO2010130666A3 (fr) Compositions désodorisantes
WO2007122581A3 (fr) Compositions et kits utiles dans le traitement de maladies respiratoires
IL187552A0 (en) Pharmaceutical compositions containing nebivolol
IL210316A (en) History of Triazol Pharmacopoeias that contain them and their uses
WO2010122332A3 (fr) Composition contenant de la gomme xanthane et une matière particulaire apte à gonfler, et ses utilisations
WO2008071800A3 (fr) Composition de matériau remplie de plastique
WO2012075015A3 (fr) Compositions pharmaceutiques orales de métronidazole
WO2008118754A3 (fr) Compositions de docétaxel nanoparticulaires stérilisées par rayonnement gamma et procédés de fabrication associés
EP1941798A3 (fr) Compositions nematicides
FI20050809A0 (fi) Värikoostumus, happi- ja/tai pH-indikaattori ja pakkaus
WO2008054484A3 (fr) Compositions, matériaux incorporant les compositions, et procédés d'utilisation des compositions et des matériaux
WO2010128526A3 (fr) Composition de polyester désoxygénant
WO2006056695A8 (fr) Bengamides possedant un cycle caprolactame substitue, procede de preparation, compositions les contenant et utilisation

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08807276

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2008807276

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE